Since addition of Th1 preserved the expansion and efficacy of IFN-γ–KO CAR-T (Figure 5C and Supplemental Figure 8B), the cause of death contributing to poor survival in Group 5 is most likely due to rapid onset of CRS and not the tumor. This evidence concerns the gene IFNG and neoplasm.